bpc 157 without mannitol Nordic Labs BPC 157 (30caps)
Description
It suggests BPC-157 could improve benzodiazepine efficacy during chronic treatment, potentially allow lower therapeutic doses, and ease withdrawal when discontinuing benzodiazepines
The variation reflects different research goals and individual responses
However, it is not FDA-approved for medical treatment or injection, and regulatory status may vary by use
Promotes angiogenesis and collagen formation
